Total Visits
Views | |
---|---|
CEMCAT ... | 254 |
Total Visits Per Month
October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | |
---|---|---|---|---|---|---|---|
CEMCAT ... | 4 | 6 | 4 | 9 | 8 | 5 | 14 |
Top country views
Views | |
---|---|
Spain | 121 |
United States | 43 |
Ireland | 11 |
China | 10 |
Sweden | 10 |
Côte d'Ivoire | 5 |
France | 4 |
South Korea | 4 |
United Kingdom | 3 |
Japan | 3 |
Top cities views
Views | |
---|---|
Barcelona | 65 |
Chandler | 12 |
Dublin | 11 |
Capellades | 10 |
Sant Feliu de Llobregat | 5 |
Ashburn | 4 |
Busan | 4 |
Daloa | 4 |
Shanghai | 4 |
Badalona | 3 |
Most visited documents
Views | |
---|---|
Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results | 491 |
Traffic Lights Intervention Reduces Therapeutic Inertia: A Randomized Controlled Trial in Multiple Sclerosis Care | 295 |
Oligoclonal bands increase the specificity of MRI criteria to predict multiple sclerosis in children with radiologically isolated syndrome | 286 |
Adherence and satisfaction of smartphone- and smartwatch-based remote active testing and passive monitoring in people with multiple sclerosis: nonrandomized interventional feasibility study | 243 |
Retinal inner nuclear layer volume reflects inflammatory disease activity in multiple sclerosis: a longitudinal OCT study | 225 |
Immunoglobulin G immune response to SARS-CoV-2 vaccination in people living with multiple sclerosis within Multiple Sclerosis Partners Advancing Technology and Health Solutions | 108 |
The state of multiple sclerosis: current insight into the patient/health care provider relationship, treatment challenges, and satisfaction | 100 |
Increased NLRP3 Inflammasome Activation and Pyroptosis in Patients With Multiple Sclerosis With Fingolimod Treatment Failure | 99 |
Immunosenescence in multiple sclerosis: the identification of new therapeutic targets | 95 |
Cognitive assessment in patients with multiple sclerosis: A Spanish consensus | 89 |